Autonomic Health
The first AI doctor powered by your nervous system
New York, NY, United States
Autonomic Health is building the first AI doctor powered by the nervous system. It aims to shift healthcare from population-based averages to personalized, real-time experiences.
How We Help
Photos & Videos
Previous hero
Leadership
.jpg)
Problem Statement
Healthcare currently runs on population averages and waits for symptoms. Autonomic Health believes the same shift to the individual that transformed media is now possible in healthcare, using the nervous system as the core signal.
Core Technology
An AI-powered clinical decision support system (CAJAL) that interprets heart rate data from any wearable to reconstruct and clinically read both branches of the autonomic nervous system (ANS), combined with 21 years of established treatment protocols for dysautonomia.
Key Differentiators
["The only system capable of clinically reading both branches (sympathetic + parasympathetic) of the ANS directly from any wearable device at home.", "Backed by 21 years of proprietary treatment protocols for dysautonomia, delivered through clinical decision support.", "Exclusive access to the largest branch-level autonomic dataset, continuously growing.", "Patent-pending technology for ANS reconstruction from heart rate data.", "FDA-cleared predicate device with a history of 1M+ patients and 700+ clinics since 2006 (for the underlying protocol/measurement)."]
Clinical Focus
Autonomic Nervous System, Dysautonomia
Target Customers
Clinics, Physicians, Hospitals, Specialists
Product Stage
GA
Company Info
- Business Model
- B2B to clinics/healthcare providers, operating on a cash-pay model for initial test sales, with an underlying B2B2C patient engagement for ongoing monitoring and treatment adherence.
- Total Funding
- Only accessible to MedStartr community members. Join now
Only accessible to MedStartr community members.
Join now - Website
- autonomichealth.ai/
Categories
Disease Areas
Technologies
Clinical & IP
Clinical Validation
The underlying protocol and measurement have been used since 2001, with an FDA-cleared device sold since 2006, leading to 1M+ patients tested across 700+ clinics. Autonomic Health's at-home version of the test runs the same protocol with >92% concordance to the FDA-cleared reference. The AI model, CAJAL, is live in four clinics under an IRB study. Clinical outcomes from the CMO's practice, which developed the protocols, include reversing 200+ heart failure cases to >45% ejection fraction (zero ICD therapy), recovery for 250+ Long COVID patients, and 500+ Type-2 Diabetes patients taken off insulin.
IP Protection
Patent pending
Only accessible to MedStartr community members.
Join nowWhat do you think of Autonomic Health?
A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.